期刊文献+

CD4^+CD29^+T细胞在肺癌患者的表达及其与肿瘤病理学类型及分期的相关性 被引量:3

Correlation between CD4^+CD29^+T cells and the pathological typing and staging for patients with primary pulmonary carcinoma
下载PDF
导出
摘要 目的:探讨肺癌患者CD4+CD29+T细胞与病理类型及分期的相关性。方法:采用流式细胞术检测60例肺癌患者外周血CD4+CD29+T细胞、γ干扰素(IFN-γ)及肿瘤坏死因子α(TNF-α),探讨三者与病理类型及分期的相关性。结果:(1)肺癌患者CD4+CD29+T细胞及TNF-α百分含量均较对照组显著升高(P<0.05),而IFN-γ显著降低(P<0.05);(2)肺癌患者鳞癌、腺癌、大细胞癌及小细胞癌分别为23、17、11及9例;0、Ⅰ、Ⅱ及Ⅲ期患者分别为15、15、17及13例;(3)CD4+CD29+T细胞及TNF-α百分含量与病理类型及分期均呈显著正相关性,但IFN-γ与病理类型及分期呈显著负相关性(r绝对值均>0.65,均P<0.05)。结果:CD4+CD29+T细胞及TNF-α含量升高、IFN-γ降低是肺癌的一个重要免疫学特征,且与病理类型及分期密切相关。 Objective To explore the correlation between CD4^+CD29^+T cells and the pathological typing and staging for patients with primary pulmonary carcinoma. Methods Flow cytometry was used to detect peripheral blood CD4^+CD29^+T cells, gamma interferon (IFN-γ) and tumor neerdsis factor alpha (TNF-α) of 60 patients with lung cancer. The relationships between them and the pathological typing and staging were studied. Results (1) The CD4^+CD29^+T cellsand TNF-α percentages in thecancer patients were significantly higher than those of the control group (P 〈 0.05), while IFN-γ/was significantly reduced (P 〈 0.05) ; (2) Amongthe cancer patients, there were 23 cases of squamous carcinoma, 17 cases of adenocarcinoma, 11 cases of large cell carcinoma and 9 cases of small cell carcinoma. The numbers of the cases at the stage of 0, Ⅰ , Ⅱ and Ⅲ were 15, 15, 17 and 13, respectively. (3) The percentages of CD4^+CD29^+T cells and TNF-α had significantly positive correlation with the pathological classification and staging, but IFN-γ-was negatively correlated with pathological typing and staging (r 〉 0.65, P 〈 0.05). Conclusion Theincreased CD4+CD29+T cells and TNF-α, together with decreased IFN-γ/arehighly indicative of immunological characteristics of lung cancer, and closely related to the pathological typing and staging.
出处 《实用医学杂志》 CAS 北大核心 2015年第15期2477-2479,共3页 The Journal of Practical Medicine
关键词 肺癌 CD4^+CD29^+T细胞 细胞因子 病理学类型 肿瘤分期 Lung cancer CD4^+CD29^+T cells Cytokines Pathological typing Tumor staging
  • 相关文献

参考文献11

二级参考文献46

  • 1岳东升,王长利.肺癌引流区淋巴结免疫状况[J].中国肿瘤临床,2007,34(3):177-180. 被引量:1
  • 2Roncarolo M G,Levings M K.The role of different subsets of T regulatory cells in controlling autoimmunity[J].Curr Opinion Immunol,2000,12(6):676-683.
  • 3Jonuleit H,Scbmitt E.The regulatory T cell family:distinct subsets and their interrelation[J].J Immunol,2003,171 (12):6323-6327.
  • 4Wolf AM,Wolf D,Steurer M,et al.Increase of regulatory T cells in the peripheral blood of cancer patients[J].Clin Cancer Res,2003,9 (2):606-612.
  • 5Ioannides C G,Whiteside T L.T cell recognition of human tumors:implications for molecular immunotherapy of cancer[J].Clin Immunol Immunopathol,1993,66 (2):91-106.
  • 6Monsurro V,Wang E,Panelli M C,et al.Activespecificimmunization against melanoma:is the problem at the receiving end[J]? Semin Cancer Biol,2003,13(6):473-480.
  • 7Shevach EM,McHngh R S,Piccirillo C A,et al.Control of T-cell activation by CD4+CD25+suppressor T cells[J].Immunol Rev,2001,182:58-67.
  • 8Thornton A M,Shevach E M.CD4+CD25+immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production[J].Exp Med,1998,188(2):287-296.
  • 9Takahashi T,Kuniyasu Y,Toda M,et al.Immunologic selftolerance maintained by CD25+CD4+naturally anergic and suppressive T cells:induction of autoimmune disease by breaking their anergic/suppressive state[J].Int Immunol,1998,10(9):1969-1980.
  • 10Zhang L,Conejo-Garcia J R,Katsaros D,et al.Intratumoral T cells,recurrence,and survival in epithelial ovarian cancer[J].N Engl J Med,2003,348(3):203-213.

共引文献65

同被引文献35

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部